A Scalable Nutrition Adherence Intervention
A Scalable Nutrition Intervention to Improve Gut and Brain Health in Underserved Rural Older Adults With and Without Mild Cognitive Impairment
1 other identifier
interventional
61
1 country
1
Brief Summary
Objective 1: To scale-up the nutrition adherence intervention for testing in racially diverse rural communities in North Florida. The investigators hypothesize that: 1\. The protocol will produce at least 75% of participants obtaining measurable levels of urine ketones (e.g., good adherence) in the Modified Mediterranean-Ketogenic diet (MMKD) group and an average score of \>6 on the MEDAS questionnaire in the Mediterranean group during the 10-week program. Further, we hypothesize that the use of ongoing monthly support groups will bolster long-term adherence. Objective 2: To evaluate the effects of adherence to Mediterranean versus MMKD on novel gut-brain axis markers of Alzheimer's disease pathogenesis in individuals with mild cognitive impairment compared to cognitively normal older adults. The investigators hypothesize that individuals with mild cognitive impairment will:
- 1.Have greater evidence of gut dysbiosis at baseline than cognitively normal controls and
- 2.Will demonstrate greater increases in beneficial gut microbial metabolites in response to adherence to Mediterranean-Ketogenic nutrition and the Mediterranean diet compared to CN controls.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable alzheimer-disease
Started Nov 2023
Typical duration for not_applicable alzheimer-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 30, 2023
CompletedFirst Posted
Study publicly available on registry
November 8, 2023
CompletedStudy Start
First participant enrolled
November 30, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 18, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2026
CompletedMarch 11, 2026
March 1, 2026
2.2 years
October 30, 2023
March 9, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Ketosis (adherence)
Participants will show measurable levels of ketones using at-home urinalysis test strips by week 10 of the intervention, as evidenced by small trace amounts of ketones on the urine strips.
Baseline, 10-weeks, 6 months, 12 months
Mediterranean Diet (adherence)
Participants will show acceptable adherence to a Mediterranean diet by week 10 of the intervention, as shown by an average score of \>6 (moderate) on Mediterranean Diet Adherence Screener (MEDAS) questionnaire. Dietary adherence will also be calculated based on composition of macros and micronutrients using participant food logs.
Baseline, 10-weeks, 6 months, 12 months
Gut Microbial Metabolites
Participants with MCI will show greater increases in beneficial gut microbial metabolites in response to M-KN and the Mediterranean diet compared to CN controls demonstrating beneficial changes in the gut brain axis.
Baseline, 10-weeks, 6 months, 12 months
Secondary Outcomes (1)
Clinical signal of cognitive effect
Baseline, 10-weeks, 6 months, 12 months
Other Outcomes (6)
Total cholesterol
Baseline, 10-weeks, 6 months, 12 months
Blood glucose levels
Baseline, 10-weeks, 6 months, 12 months
Sleep
Baseline, 10-weeks, 6 months, 12 months
- +3 more other outcomes
Study Arms (4)
MMKD ICAN Program + Monthly Support Groups
EXPERIMENTALThe M-KN adherence program will consist of 10, 1-hour weekly group meetings, which will take place via HIPAA-compliant Zoom. Sessions will be devoted to providing nutrition information, building group support, identifying participant goals, and working as a group to overcome barriers. Participants will be provided with access to ongoing monthly support groups after the 10-week program ends.
Mediterranean ICAN Adherence Program + Monthly Support Groups
ACTIVE COMPARATORThe Mediterranean ICAN adherence program will consist of 10, 1-hour weekly group meetings, which will primarily take place via HIPAA-compliant Zoom. Sessions will be devoted to providing nutrition information, building group support, identifying participant goals, and working as a group to overcome barriers. Participants will be provided with access to ongoing monthly support groups after the 10-week program ends.
MMKD ICAN Adherence Program + online resources
EXPERIMENTALThe MMKD ICAN adherence program will consist of 10, 1-hour weekly group meetings, which will take place via HIPAA-compliant Zoom. Sessions will be devoted to providing nutrition information, building group support, identifying participant goals, and working as a group to overcome barriers. Participants will be provided with access to an online forum after the program.
Mediterranean ICAN Adherence Program + Online Resources
ACTIVE COMPARATORThe Mediterranean ICAN adherence program will consist of 10, 1-hour weekly group meetings, which will take place via HIPAA-compliant Zoom. Sessions will be devoted to providing nutrition information, building group support, identifying participant goals, and working as a group to overcome barriers. Participants will be provided with access to an online forum after the program.
Interventions
The ICAN program consists of 10 weekly meetings. The first session occurrs in-person and lasts 90 minutes, and all remaining sessions are 60 minutes and take place via HIPAA-compliant Zoom. The ICAN program is led by two trained facilitators (Bachelor's level or higher facilitators). Sessions are devoted to providing accessible nutrition education, building group support, identifying participant goals, teaching new behavioral and cognitive skills, and working collaboratively to overcome barriers. Information is presented using pre-recorded videos with built-in stop points throughout the sessions for questions and discussion. The program is designed to enhance adherence to a variety of whole-foods based diets by providing a structure that can easily be adapted to to input specialized dietary information. In addition to basic nutrition education, the base ICAN framework also includes modules for managing stress, improving sleep quality, and increasing physical activity.
The ICAN program consists of 10 weekly meetings. The first session occurrs in-person and lasts 90 minutes, and all remaining sessions are 60 minutes and take place via HIPAA-compliant Zoom. The ICAN program is led by two trained facilitators (Bachelor's level or higher facilitators). Sessions are devoted to providing accessible nutrition education, building group support, identifying participant goals, teaching new behavioral and cognitive skills, and working collaboratively to overcome barriers. Information is presented using pre-recorded videos with built-in stop points throughout the sessions for questions and discussion. The program is designed to enhance adherence to a variety of whole-foods based diets by providing a structure that can easily be adapted to to input specialized dietary information. In addition to basic nutrition education, the base ICAN framework also includes modules for managing stress, improving sleep quality, and increasing physical activity.
Eligibility Criteria
You may qualify if:
- Ages 55-85
- converted telephone MoCA total score: MCI = 17 ≤ 26, CN= ≥27 and/or and/or MCS MCI≥3, CN\<3
- interest in participating in a nutrition program
- stable medical condition (at least 3 months prior to screening visit) at the discretion of study physician
- stable on medications if any (at least 4 weeks prior to screening visit) at the discretion of study physician
- able to complete the required assessments
You may not qualify if:
- MoCA ≤ 16, or diagnosis of neurodegenerative illness (except MCI or early AD in the MCI group)
- current evidence or history in the last 1 year of focal brain lesion, head injury with loss of consciousness, or any major psychiatric disorder including psychosis, bipolar disorder, severe major depression (PHQ-9 \> 20), alcohol or substance abuse, or disordered eating symptoms (SCOFF \> 2)
- sensory impairment (visual or auditory) that might preclude participant from participating in the study
- serious medical risk or organ failure, such as type 1 diabetes mellitus, recent cardiac event (e.g. heart attack, angioplasty)
- prescribed Warfarin, insulin, or immunosuppressants
- use of medications including anticonvulsants, drugs with potential interfering CNS effects (except cholinesterase inhibitors or memantine), and medications with known anticholinergic activity
- a nut or fish allergy (does not include shellfish)
- current use of highly restrictive or specialized diet regimen (e.g., vegan, use of MAOIs etc.)
- major digestive disorders, absorption issues, or surgeries that could be exacerbated by dietary intervention
- Non-English speaking.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
2010 Levy Ave - Center for Translational Behavioral Science
Tallahassee, Florida, 32303, United States
Related Publications (1)
Sheffler JL, Meng Z, Sims T, Caimary VG, Nagpal R, Mompremier G. Facilitators and Barriers to Adherence and Engagement in a Lifestyle Intervention for High-Risk Older Adults: A Multi-Trial Analysis. Nutrients. 2026 Feb 26;18(5):747. doi: 10.3390/nu18050747.
PMID: 41829915DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
October 30, 2023
First Posted
November 8, 2023
Study Start
November 30, 2023
Primary Completion
February 18, 2026
Study Completion
May 1, 2026
Last Updated
March 11, 2026
Record last verified: 2026-03